Three Questions to the Editorials Author
Reprinted with permission of Andrea R. Genazzani, MD & GynoEndo News
Question 1:
Does progesterone exert stimulatory effect on uterine myoma growth?
Answer:
Although the action of progesterone (P4) on uterine myoma growth is not simple, the net effect of P4 on uterine myoma growth is in favor of the increase in the proliferative activity for leiomyoma cells. P4 contributes to leiomyoma cell growth through stimulating EGF expression and to the cell survival through stimulating Bcl-2 expression and inhibiting TNFα expression in the cells. However, P4 also exerts an inhibitory effect on leiomyoma cell growth and survival through inhibiting IGF-I expression in the cells. This suggests that P4 may have dual actions on uterine myoma growth: one is to stimulate and the other is to inhibit leiomyoma cell growth.
Question 2:
What is the relationship in regulating uterine myoma growth between estrogen and progesterone?
Answer:
Historically estrogen has been attributed to the pathogenesis of uterine myoma. However, it is now evident that P4 and estradiol (E2) act in combination to stimulate the EGF/EGF receptor system in regulating leiomyoma cell growth. E2 stimulates EGF receptor expression in the cells, while P4 stimulates EGF expression in uterine leiomyoma cells.
Question 3:
Do uterine myomas increase in size during pregnancy?
Answer:
Although until recently it has been described in textbooks that uterine myomas increase in size during pregnancy, uterine myomas do not necessarily increase in size during pregnancy despite the increased circulating concentrations of E2 and P4. The dual actions of P4 may explain, at least in part, why most uterine myomas identified early in pregnancy remain the same size or even shrink over the course of pregnancy.
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Unveiling the complexities of preterm birth risk from nativity, ethnicity, and race
March 22nd 2024A recent study dissected the relationships between maternal nativity, ethnicity, and race in influencing preterm birth rates, shedding light on disparities and suggesting avenues for future research.
Read More
Study reveals link between opioid dosage and spontaneous preterm birth risk
February 21st 2024Recent research highlighted an association between the total dose of prescribed opioids during pregnancy and the heightened risk of spontaneous preterm birth, emphasizing the need for judicious opioid use in pain management for expectant mothers.
Read More
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Unveiling the complexities of preterm birth risk from nativity, ethnicity, and race
March 22nd 2024A recent study dissected the relationships between maternal nativity, ethnicity, and race in influencing preterm birth rates, shedding light on disparities and suggesting avenues for future research.
Read More
Study reveals link between opioid dosage and spontaneous preterm birth risk
February 21st 2024Recent research highlighted an association between the total dose of prescribed opioids during pregnancy and the heightened risk of spontaneous preterm birth, emphasizing the need for judicious opioid use in pain management for expectant mothers.
Read More
2 Commerce Drive
Cranbury, NJ 08512